First-Line Treatment of Waldenström’s Macroglobulinaemia: Considerations Based on the Dutch National Guideline

First-Line Treatment of Waldenström’s Macroglobulinaemia: Considerations Based on the Dutch National Guideline

Waldenström macroglobulinemia (WM) is a rare B-cell Non-Hodgkin Lymphoma. There are only few prospective randomized clinical trials to guide treatment recommendations and there is no international consensus on a preferred first line treatment approach. In the recently revised Dutch guideline for WM,...

Full description

Bibliographic Details
Main Authors: Karima Amaador, Marie José Kersten, Hein P. J. Visser, Laurens Nieuwenhuizen, Roelandt F. J. Schop, Martine E. D. Chamuleau, Gerjo A. Velders, Monique C. Minnema, Josephine Mathilde Iris Vos
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Hemato
Subjects:
Waldenstrom’s Macroglobulinemia
guideline
ibrutinib
zanubrutinib
DRC
bendamustine
Online Access:https://www.mdpi.com/2673-6357/3/4/47

Internet

https://www.mdpi.com/2673-6357/3/4/47

Similar Items